For the year ending 2025-12-31, RNXT made $1,123K in revenue. -$11,168K in net income. Net profit margin of -994.48%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenue | 1,123 | 43 | ||
| Cost of revenue | 327 | - | ||
| Gross profit | 796 | 43 | ||
| Research and development | 6,269 | 6,025 | ||
| Selling, general and administrative | 7,037 | 4,988 | ||
| Total operating expenses | 13,306 | 11,013 | ||
| Loss from operations | -12,510 | -10,970 | ||
| Change in fair value of warrant liability | -915 | -1,772 | ||
| Interest income, net | 427 | 384 | ||
| Total other income, net | 1,342 | 2,156 | ||
| Net loss | -11,168 | -8,814 | ||
| Basic EPS | -0.32 | -0.4 | ||
| Diluted EPS | -0.32 | -0.4 | ||
| Basic Average Shares | 35,333,127 | 22,271,163 | ||
| Diluted Average Shares | 35,333,127 | 22,271,163 | ||
RenovoRx, Inc. (RNXT)
RenovoRx, Inc. (RNXT)